| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | US20080260726 Using cathepsin C gene expression as evaluative tool in identifying modulators for prevention and treatment of inflammatory or obstructive diseases of the respiratory system |
| 10/23/2008 | CA2683914A1 Oligo-guluronate and galacturonate compositions |
| 10/23/2008 | CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect |
| 10/23/2008 | CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1982986A1 Pyrrolopyridazinone compound |
| 10/22/2008 | EP1982732A2 Factor VII or VIIA-like molecules |
| 10/22/2008 | EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents |
| 10/22/2008 | EP1982709A1 Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
| 10/22/2008 | EP1981572A2 Pulmonary delivery of alpha-i proteinase inhibitor |
| 10/22/2008 | EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/22/2008 | EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 10/22/2008 | EP1408984B1 Organo-phosphorous compounds for activating gamma/delta t cells |
| 10/22/2008 | EP1404349B1 Fat-binding polymers |
| 10/22/2008 | EP1368371B1 Transfection complexes |
| 10/22/2008 | EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists |
| 10/22/2008 | CN101291667A Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 10/22/2008 | CN101291663A Method and means of preventing and treating sleep disordered breathing |
| 10/22/2008 | CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents |
| 10/22/2008 | CN101288767A Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method |
| 10/22/2008 | CN101288722A Camellia oil liposome for treating snore and xerostomia |
| 10/22/2008 | CN101288706A Xanthium sibiricum honey compound soup for treating nasal sinusitis |
| 10/22/2008 | CN101288663A Method for preparing aqueous wrapped pellet |
| 10/22/2008 | CN101288658A Compound ambroxol sustained-release drop pills and preparation method thereof |
| 10/22/2008 | CN101288479A Loquat leaf lozenge |
| 10/22/2008 | CN100427117C Chinese proprietary medicine |
| 10/22/2008 | CN100427110C Asiatic moonseed rhizome extract and its prepn and use |
| 10/22/2008 | CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 10/22/2008 | CN100427075C Isatidis soft capsule and preparing method thereof |
| 10/22/2008 | CN100427071C Cold treating dripping pills and its preparation method |
| 10/22/2008 | CN100427070C Dripping pills for treating all kinds of rhinitis and its preparation method |
| 10/21/2008 | US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis |
| 10/21/2008 | US7439393 Phenethanolamine derivatives for treatment of respiratory diseases |
| 10/21/2008 | US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 10/21/2008 | US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 10/21/2008 | US7439240 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example |
| 10/21/2008 | US7439233 Vaccine for house dust mite allergen using naked DNA |
| 10/21/2008 | CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 10/21/2008 | CA2438294C Pyridopyrimidine or naphthyridine derivative |
| 10/21/2008 | CA2282345C Pharmaceutical composition |
| 10/21/2008 | CA2247998C Fragments of cr1 and their use |
| 10/21/2008 | CA2174472C Arylalkylpyridazinones |
| 10/21/2008 | CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange |
| 10/16/2008 | WO2008124763A1 Edible products for treatment of nasal passages |
| 10/16/2008 | WO2008124128A2 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| 10/16/2008 | WO2008123821A1 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 10/16/2008 | WO2008123758A1 Pharmaceutical composition comprising n-sulphoethylnicotinamide useful in treatment or prevention of a pulmonary disease and use of said composition for treatment or prevention of said disease |
| 10/16/2008 | WO2008123582A1 Tetrahydroisoquinoline compound |
| 10/16/2008 | WO2008123471A1 Composition for cleaning nasal fossa |
| 10/16/2008 | WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same |
| 10/16/2008 | WO2008123017A1 Novel diamide derivative |
| 10/16/2008 | WO2008122784A1 Quinolines and their therapeutic use |
| 10/16/2008 | WO2008122765A1 New compounds and their uses 707 |
| 10/16/2008 | WO2008099178A3 Binding members for ige molecules |
| 10/16/2008 | WO2008096149A3 Napadisylate salt of a muscarinic m3 antagonist |
| 10/16/2008 | WO2008089268A3 Methods and compositions for treating conditions associated with infection and/or inflammation |
| 10/16/2008 | WO2006069329A3 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 10/16/2008 | US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability |
| 10/16/2008 | US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 10/16/2008 | US20080255193 Comprising NK3 receptor antagonist talnetant, povidone, erythritol and Sodium Lauryl Sulfate; erythritol used as soluble filler in preparation of stable drug; dosage tablet or capsule |
| 10/16/2008 | US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 10/16/2008 | US20080255162 Treating diseases mediated by phosphatidyl inositol 3-kinase; cardiovascular disorders; anticarcinogenic, antiarthritic, anticoagulant, antiinflammatory, antiischemic,and hypotensive agents; chronic obstructive pulmonary disease; autoimmune diseases; diabetes, atherosclerosis, bronchitis, strokes |
| 10/16/2008 | US20080255160 Mapk/erk kinase inhibitors |
| 10/16/2008 | US20080255150 2-[(1-Piperazinyl)methyl]phenylacetic acid derivatives such as 3-(4-chloro-2-{[(3S)-3-methyl-4-(phenylacetyl)piperazin-1-yl]methyl}phenyl)propanoic acid; antihistamines, bronchodilator agents; asthma, rhinitis; treating prostaglandin D2 mediated disease |
| 10/16/2008 | US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders |
| 10/16/2008 | US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 10/16/2008 | US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 10/16/2008 | US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 10/16/2008 | US20080255100 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 10/16/2008 | US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 10/16/2008 | US20080255043 SP-D induces and increases apoptosis specifically in activated eosinophils derived from hypereosinophilic patients for the resolution of eosinophilia and eosinophil mediated pathogenic effects in eosinophil related diseases and disorders other than airway-hyperresponsiveness |
| 10/16/2008 | US20080255036 Substituted thiophenes |
| 10/16/2008 | US20080254506 Claudin polypeptides |
| 10/16/2008 | US20080254127 Inhalation particles incorporating a combination of two or more active ingredients |
| 10/16/2008 | US20080254114 Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles |
| 10/16/2008 | US20080254113 Microemulsion Formulations Comprising Particular Substance P Antagonists |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254022 Method of Treating Airway Diseases With Beta-Adrenergic Inverse Agonists |
| 10/16/2008 | CA2683697A1 Methods and compositions for treating sleep-related breathing disorders |
| 10/16/2008 | CA2681221A1 Isoquinolinone derivatives and their uses |
| 10/16/2008 | CA2680682A1 Quinolines and their therapeutic use |
| 10/15/2008 | EP1980618A2 Human DNASE I variants |
| 10/15/2008 | EP1979355A1 Spiro imidazole derivatives as ppar modulators |
| 10/15/2008 | EP1978990A2 Compositions comprising igbpma and uses thereof |
| 10/15/2008 | EP1978955A1 New pharmaceutical compositions based on anticholinergics and andolast |
| 10/15/2008 | EP1896416B1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 10/15/2008 | EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 10/15/2008 | EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 10/15/2008 | EP1446162B1 Combination motif immune stimulatory oligonucleotides with improved activity |
| 10/15/2008 | EP1444202B1 Novel metalloproteinase inhibitors |
| 10/15/2008 | EP1429712B1 Method for treating bronchial constriction and bronchospasm |
| 10/15/2008 | EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 10/15/2008 | EP1379207A4 Composition for freshening nostrils and sinus cavities |
| 10/15/2008 | EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 10/15/2008 | EP1319008B1 Water soluble rapamycin esters |
| 10/15/2008 | EP1272515B1 Immunoregulator |
| 10/15/2008 | EP1126826B1 Multiparticulate modified release composition of methylphenidate |
| 10/15/2008 | EP0841946B2 Methods for treatment of allergic asthma |